期刊文献+

外源性一氧化碳释放分子2对急性肺损伤时肺部炎症反应的抑制作用 被引量:5

Inhibitory effect of extrinsic CO-releasing molecules-2(CORM-2) on inflammatory responses in mice with LPS-induced acute lung injury
下载PDF
导出
摘要 目的:探讨外源性一氧化碳释放分子(CORM)2对急性肺损伤(ALI)时肺部炎症反应的抑制作用。方法:建立小鼠LPS吸入肺损伤模型。实验动物分成4组:对照组(n=8),LPS吸入致ALI组(n=15),ALI+无活性CORM-2组(n=15)以及ALI+CORM-2组(n=15)。在自制的16cm×8 cm雾化发生罐中雾化LPS(终浓度500μg/ml),实验组小鼠在雾化罐中放置30 min,对照组小鼠置于单纯的生理盐水雾化罐30 min,ALI+CORM-2组小鼠尾静脉注射CORM-2(8 mg/kg)。检测动物肺组织髓过氧化物酶(MPO)、核因子κB(NF-κB)活性、细胞间粘附分子-1(ICAM-1)的表达,肺泡灌洗液中TNF-α和IL-1β水平。结果:ALI组肺组织中MPO及NF-κB活性迅速增强,同时肺组织ICAM-1蛋白水平亦显著升高。CORM-2干预后肺组织MPO及NF-κB活性被明显抑制(P<0.05),ICAM-1蛋白表达量也被显著抑制(P<0.05)。肺泡灌洗液中TNF-α和IL-1β水平在CORM-2干预后较ALI组明显下降(P<0.05)。结论:外源性一氧化碳释放分子能明显抑制肺组织NF-κB活性,减轻ALI肺组织粘附分子的表达,从而减轻组织中白细胞扣留,有效减轻肺部炎症反应。 Objective: To investigate the effects of extrinsic CO-releasing molecules-2(CORM-2) on attenuating pulmonary injury and the inflammatory response in LPS-induced acute lung injury of mice.Methods: Fifty-three mice were assigned to four groups.Mice in sham group(n=8) underwent sham inhalation,whereas mice in ALI(n=15) received inhalation of LPS for 30 min,mice in ALI+iCORM(n=15) underwent LPS inhalation with immediate administration of inactive CORM-2(8mg/kg,i.v.),mice in ALI+CORM(n=15) underwent LPS inhalation with immediate administration of CORM-2(8mg/kg,i.v.).PMN accumulation(MPO assay) in mice lungs and TNF-α and IL-1β in BAL fluid were determined.Activation of NF-κB and expression level of ICAM-1 in the lung were assessed.Results: Treatment of ALI mice with CORM-2 attenuated PMN accumulation and prevented activation of NF-κB in the lung.This was accompanied by a decrease of the expression of ICAM-1.In parallel,CORM-2 markedly decreased the production of inflammatory mediators in BAL fluid.Conclusion: CORM-2 attenuates the inflammatory response in the lung of LPS-induced ALI by decreasing leukocyte sequestration and interfering with NF-κB activation,expression of ICAM-1 and therefore suppressing endothelial cells pro-adhesive phenotype.
出处 《浙江大学学报(医学版)》 CAS CSCD 北大核心 2010年第5期458-463,共6页 Journal of Zhejiang University(Medical Sciences)
基金 国家自然科学基金(30772256) 江苏省自然科学基金(BK2008237)
关键词 一氧化碳/治疗应用 肺/损伤 肺/药物作用 NF-ΚB 胞间粘附分子1 Carbon monoxide/ther use Lung/inj Lung/drug eff NF-kappa B Intercellular adhesion molecule-1
  • 相关文献

参考文献1

二级参考文献37

  • 1[1]Hayashi S,Takamiya R,Yamaguchi T,Matsumoto K,Tojo SJ,Tamatani T,Kitajima M,Makino N,Ishimura Y,Suematsu M.Induction of heme oxygenase-1 suppresses venular leukocyte adhesion elicited by oxidative stress:role of bilirubin generated by the enzyme.Circ Res 1999; 85:663-671
  • 2[2]Lee TS,Chau LY.Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice.Nat Med 2002; 8:240-246
  • 3[3]Otterbein LE,Soares MP,Yamashita K,Bach FH.Heme oxygenase-1:unleashing the protective properties of heme.Trends Immunol 2003; 24:449-455
  • 4[4]Motterlini R,Mann BE,Johnson TR,Clark JE,Foresti R,Green CJ.Bioactivity and pharmacological actions of carbon monoxide-releasing molecules.Curr Pharm Des 2003; 9:2525-2539
  • 5[5]Motterlini R,Clark JE,Foresti R,Sarathchandra P,Mann BE,Green CJ.Carbon monoxide-releasing molecules:characterization of biochemical and vascular activities.Circ Res 2002; 90:E17-E24
  • 6[6]Motterlini R,Sawle P,Hammad J,Bains S,Alberto R,Foresti R,Green CJ.CORM-A1:a new pharmacologically active carbon monoxide-releasing molecule.FASEB J 2005; 19:284-286
  • 7[7]Johnson TR,Mann BE,Clark JE,Foresti R,Green CJ,Motterlini R.Metal carbonyls:a new class of pharmaceuticals? Angew Chem Int Ed Engl 2003; 42:3722-3729
  • 8[8]Foresti R,Hammad J,Clark JE,Johnson TR,Mann BE,Friebe A,Green CJ,Motterlini R.Vasoactive properties of CORM-3,a novel water-soluble carbon monoxide-releasing molecule.Br J Pharmacol 2004; 142:453-460
  • 9[9]Clark JE,Naughton P,Shurey S,Green CJ,Johnson TR,Mann BE,Foresti R,Motterlini R.Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule.Circ Res 2003; 93:e2-e8
  • 10[10]Guo Y,Stein AB,Wu WJ,Tan W,Zhu X,Li QH,Dawn B,Motterlini R,Bolli R.Administration of a CO-releasing molecule at the time of reperfusion reduces infarct size in vivo.Am J Physiol Heart Circ Physiol 2004; 286:H1649-H1653

共引文献7

同被引文献46

  • 1刘晨曦,任玲,陈红印,秦玉川.Complexin蛋白的研究进展[J].生理科学进展,2004,35(4):361-363. 被引量:2
  • 2邓硕曾,秦莉.输血相关性急性肺损伤[J].中国输血杂志,2005,18(3):254-255. 被引量:15
  • 3刘胜春,姚榛祥,孙正魁,唐华,董蒲江.HO-1在延迟性异种心脏移植排斥反应中的表达及意义[J].重庆医科大学学报,2005,30(5):655-659. 被引量:1
  • 4韦鹏,周晓红,凌毅群,戴鸿雁,黄新莉,凌亦凌.硫化氢在脂多糖所致大鼠急性肺损伤中的作用[J].基础医学与临床,2006,26(3):306-311. 被引量:19
  • 5BONE R C,BALK R A,CERRA F B,et al.Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.The ACCP/SCCM consensus conference committee.American college of chest physicians/ society of critical care medicine[J] .Chest,1992,101(6):1644-1655.
  • 6ANGUS D C,LINDE-ZWIRBLE W T,LIDICKER J,et al.Epidemiology of severe sepsis in the United States:Analysis of incidence,outcome,and associated costs of care[J] .Crit Care Med,2001,29(7):1303-1310.
  • 7CHENG B,XIE G,YAO S,et al.Epidemiology of severe sepsis in critically ill surgical patients in 10 university hospitals in China[J] .Crit Care Med,2007,35(11):2538-2546.
  • 8HOTCHKISS R S,KARL I E.The pathophysiology and treatment of sepsis[J] .N Engl J Med,2003,348(2):138-150.
  • 9DELLINGER R P,CARLET J M,MASUR H,et al.Surviving sepsis campaign guidelines for management of severe sepsis and septic shock[J] .Crit Care Med,2008,32(3):858-873.
  • 10LEVY M M,DELLINGER R P,TOWNSEND S R,et al.The surviving sepsis campaign:results of an international guideline-based performance improve-ment program targeting severe sepsis[J] .Crit Care Med,2010,38(2):367-374.

引证文献5

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部